Ronald, J., Rajagopalan, R., Cerrato, F., Nord, A. S., Hatsukami, T., Kohler, T., … Jarvik, G. P. (2011). Genetic Variation in LPAL2 , LPA , and PLG Predicts Plasma Lipoprotein(a) Level and Carotid Artery Disease Risk. Stroke, 42(1), 2–9. https://doi.org/10.1161/strokeaha.110.591230

Ronald, James, Ramakrishnan Rajagopalan, Felecia Cerrato, Alex S. Nord, Thomas Hatsukami, Ted Kohler, Santica Marcovina, Patrick Heagerty, and Gail P. Jarvik. “Genetic Variation in LPAL2 , LPA , and PLG Predicts Plasma Lipoprotein(a) Level and Carotid Artery Disease Risk.” Stroke 42, no. 1 (January 2011): 2–9. https://doi.org/10.1161/strokeaha.110.591230.

Ronald J, Rajagopalan R, Cerrato F, Nord AS, Hatsukami T, Kohler T, et al. Genetic Variation in LPAL2 , LPA , and PLG Predicts Plasma Lipoprotein(a) Level and Carotid Artery Disease Risk. Stroke. 2011 Jan;42(1):2–9.

Ronald, James, et al. “Genetic Variation in LPAL2 , LPA , and PLG Predicts Plasma Lipoprotein(a) Level and Carotid Artery Disease Risk.” Stroke, vol. 42, no. 1, Ovid Technologies (Wolters Kluwer Health), Jan. 2011, pp. 2–9. Crossref, doi:10.1161/strokeaha.110.591230.

Ronald J, Rajagopalan R, Cerrato F, Nord AS, Hatsukami T, Kohler T, Marcovina S, Heagerty P, Jarvik GP. Genetic Variation in LPAL2 , LPA , and PLG Predicts Plasma Lipoprotein(a) Level and Carotid Artery Disease Risk. Stroke. Ovid Technologies (Wolters Kluwer Health); 2011 Jan;42(1):2–9.